Alligator Bioscience Valuation
| ATORX Stock | SEK 0.53 0.02 3.64% |
Alligator Bioscience is fairly valued. Alligator Bioscience shows a prevailing Real Value of kr0.51 per share. The current price of the firm is kr0.53. Our model approximates the value of Alligator Bioscience from analyzing the firm fundamentals such as Return On Equity of -1.04, operating margin of (5.39) %, and Shares Outstanding of 220.58 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Alligator Bioscience's price fluctuation is out of control at this time. Calculation of the real value of Alligator Bioscience is based on 3 months time horizon. Increasing Alligator Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Alligator stock is determined by what a typical buyer is willing to pay for full or partial control of Alligator Bioscience AB. Since Alligator Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alligator Stock. However, Alligator Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.53 | Real 0.51 | Hype 0.53 | Naive 0.54 |
The intrinsic value of Alligator Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alligator Bioscience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Alligator Bioscience AB helps investors to forecast how Alligator stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alligator Bioscience more accurately as focusing exclusively on Alligator Bioscience's fundamentals will not take into account other important factors: Alligator Bioscience Total Value Analysis
Alligator Bioscience AB is presently projected to have takeover price of 236.82 M with market capitalization of 431.05 M, debt of 3.51 M, and cash on hands of 278.15 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Alligator Bioscience fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
236.82 M | 431.05 M | 3.51 M | 278.15 M |
Alligator Bioscience Investor Information
About 52.0% of the company shares are held by company insiders. The book value of Alligator Bioscience was presently reported as 0.4. The company recorded a loss per share of 0.6. Alligator Bioscience had not issued any dividends in recent years. The entity had 155:142 split on the 9th of November 2021. Based on the measurements of operating efficiency obtained from Alligator Bioscience's historical financial statements, Alligator Bioscience AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Alligator Bioscience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Alligator Bioscience has an asset utilization ratio of 3.88 percent. This implies that the Company is making kr0.0388 for each dollar of assets. An increasing asset utilization means that Alligator Bioscience AB is more efficient with each dollar of assets it utilizes for everyday operations.Alligator Bioscience Ownership Allocation
Alligator Bioscience holds a total of 220.58 Million outstanding shares. Alligator Bioscience AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Alligator Bioscience Profitability Analysis
The company reported the revenue of 12.94 M. Net Loss for the year was (141.74 M) with loss before overhead, payroll, taxes, and interest of (111.72 M).About Alligator Bioscience Valuation
The stock valuation mechanism determines Alligator Bioscience's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Alligator Bioscience based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alligator Bioscience. We calculate exposure to Alligator Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Alligator Bioscience's related companies.Alligator Bioscience AB develops antibody-based pharmaceuticals for cancer treatment. Alligator Bioscience AB was founded in 2001 and is headquartered in Lund, Sweden. Alligator Bioscience operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 56 people.
8 Steps to conduct Alligator Bioscience's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Alligator Bioscience's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Alligator Bioscience's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Alligator Bioscience's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Alligator Bioscience's revenue streams: Identify Alligator Bioscience's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Alligator Bioscience's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Alligator Bioscience's growth potential: Evaluate Alligator Bioscience's management, business model, and growth potential.
- Determine Alligator Bioscience's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Alligator Bioscience's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Alligator Stock Analysis
When running Alligator Bioscience's price analysis, check to measure Alligator Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alligator Bioscience is operating at the current time. Most of Alligator Bioscience's value examination focuses on studying past and present price action to predict the probability of Alligator Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alligator Bioscience's price. Additionally, you may evaluate how the addition of Alligator Bioscience to your portfolios can decrease your overall portfolio volatility.